Decoy Therapeutics Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Decoy Therapeutics Inc. stock issued during period, value, new issues for the quarter ending 2026-06-30 was $2.61M, a 5961.15% increase year-over-year.
- Decoy Therapeutics Inc. stock issued during period, value, new issues for the quarter ending 2025-09-30 was $5.93M, a 305.68% increase year-over-year.
- Decoy Therapeutics Inc. stock issued during period, value, new issues for the quarter ending 2025-06-30 was $43.08K, a 33.80% decline year-over-year.
- Decoy Therapeutics Inc. stock issued during period, value, new issues for the quarter ending 2025-03-31 was $226.17K, a 595084.21% increase year-over-year.
- Decoy Therapeutics Inc. stock issued during period, value, new issues for fiscal 2025 was $12.37M, a 710.68% increase from fiscal 2024.
- Decoy Therapeutics Inc. stock issued during period, value, new issues for fiscal 2024 was $1.53M, a 77.94% decline from fiscal 2023.
- Decoy Therapeutics Inc. stock issued during period, value, new issues for fiscal 2023 was $6.92M, a 248.66% increase from fiscal 2022.
- Decoy Therapeutics Inc. stock issued during period, value, new issues for fiscal 2022 was $1.98M, a 92.73% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-06-30 | $2.61M 10-Q · filed 2026-08-12 | |
| 2025-12-31 | $12.37M 10-K · filed 2026-03-31 | |
| 2025-09-30 | $5.93M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $43.08K 10-Q · filed 2026-08-12 | |
| 2025-03-31 | $226.17K 10-Q · filed 2026-08-12 | |
| 2024-12-31 | $1.53M 10-K · filed 2026-03-31 | |
| 2024-09-30 | $1.46M 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $65.08K 10-Q · filed 2025-11-14 | |
| 2024-03-31 | $38.00 10-Q · filed 2025-11-14 | |
| 2023-12-31 | $6.92M 10-K · filed 2025-03-21 | |
| 2023-09-30 | $59.00 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $6.61M 10-Q · filed 2024-11-14 | |
| 2023-03-31 | $311.68K 10-Q · filed 2024-11-14 | |
| 2022-12-31 | $1.98M 10-K · filed 2024-03-22 | |
| 2022-06-30 | $1.99M 10-Q · filed 2023-11-09 | |
| 2022-03-31 | $487.90K 10-Q · filed 2022-11-10 | |
| 2021-12-31 | $27.29M 10-K · filed 2023-03-27 | |
| 2021-09-30 | $406.36K 10-Q · filed 2022-11-10 | |
| 2021-03-31 | $26.85M 10-Q · filed 2022-11-10 | |
| 2020-12-31 | $14.80M 10-K · filed 2022-03-25 | |
| 2020-09-30 | $5.33M 10-Q · filed 2021-11-04 | |
| 2020-03-31 | $9.47M 10-Q · filed 2021-11-04 | $12.02M derived: sum of 4 quarters · filed 2021-11-04 |
| 2019-12-31 | $2.55M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $6.93M 10-K · filed 2021-03-18 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | |
| 2019-03-31 | $4.38M 10-Q · filed 2020-11-12 | |
| 2018-12-31 | $2.03M 10-K · filed 2020-03-23 | |
| 2018-06-30 | $2.03M 10-Q · filed 2019-11-12 | |
| 2015-12-31 | $79.86M 10-K · filed 2018-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |